Stocks to sell

DraftKings (DKNG) CEO Jason Robins caught flak for not buying more DKNG stock when it was trading so low. Investors look to insider buying as a sign of confidence in the company’s plan.   Is Jason Robins doing enough to earn his CEO compensation?  Source: Tada Images / Shutterstock.com A recent spat ensued on Twitter between
0 Comments
DraftKings (DKNG) has been brutalized in the current market selloff, down 52% year-to-date. Much of the problem stems from the company’s heavy marketing spending, which has led to mounting losses. While some analysts are turning bullish on DKNG stock after the selloff, the risks of taking a position remain too great. Source: Tada Images /
0 Comments
Due to overvaluation, the following stocks are likely to decline more before they start to bottom out. Apple (AAPL): Lack of stimulus and inflation will likely lead to lower profits this year. Microsoft (MSFT): Declining quarterly net income and the announcement to almost double employee salaries might lead to a disappointing earnings report. Prologis (PLD):
0 Comments
Shares of Sunrun (RUN) have reversed higher after the company’s Q1 results. The company remains unprofitable and faces headwinds. It is not clear whether RUN stock has found a bottom or has further to fall. Source: IgorGolovniov / Shutterstock.com Have shares of solar panel company Sunrun (NASDAQ:RUN) finally hit bottom? Signs look encouraging. On May
0 Comments
Meme momentum is fading rapidly for AMC Entertainment (AMC) and AMC stock. Positive sentiment alone accounted for AMC’s price rise. Investors should take this opportunity to bail from AMC now. Investors may cite improving movie attendance as a reason to buy AMC Entertainment (NYSE:AMC) stock. At the same time, they are shunning Netflix (NASDAQ:NFLX) and
0 Comments
Nio’s (NIO) Singapore listing isn’t going to do investors any favors. Recent earnings results show weakness. Nio is a surprisingly minor player in its biggest market. I’ve long been a proponent of Chinese EV manufacturer Nio (NYSE:NIO) and its stock. However, a host of recent factors is causing me to change that opinion. Nio’s current
0 Comments
Strong first quarter (Q1) earnings have AMC (AMC) stock momentarily moving upward.  A short squeeze potential exists again for AMC stock. The earnings beat is also affecting other meme stock prices.  Source: QualityHD / Shutterstock.com If nothing else, AMC Entertainment (NYSE:AMC) stock continues to prove its ability to shock the market. The news this time
0 Comments
Tesla (TSLA) stock is overvalued and Chief Executive Officer (CEO) Elon Musk is bored. The company has yet to begin planning on a true mass market car. Tesla loses share wherever the middle class gets into the electric revolution. Source: Ivan Marc / Shutterstock.com I am not a fan of Tesla (NASDAQ:TSLA) or TSLA stock.
0 Comments
Some Chinese stocks have generated the occasional pop, but the risk-reward is skewed bearishly. Alibaba (BABA): China’s flagship has been plunging for the better part of the trailing year. JD.com (JD): JD.com is now reflecting consumer weaknesses pinged earlier this year. Ping An Insurance (PNGAY): Ping An is a worryingly exposed company, especially for an
0 Comments
Late last month, virtual healthcare company Teladoc Health (TDOC) experienced a post-earnings plunge. Despite the big drop, a recovery will prove difficult. With the prognosis unchanged, though, steer clear of TDOC stock. Source: Postmodern Studio / Shutterstock.com Like many pandemic-era favorites, the situation has gone from bad to worse when it comes to shares of
0 Comments
Several SPAC mergers could be abandoned this year, with these three at particular risk. Riley Principal 150 Merger Corp (NASDAQ:BRPM): FaZe Clan’s poor liquidity and missed targets could make investors develop cold feet as the SPAC merger deal progresses. Digital World Acquisition Corp (NASDAQ:DWAC): Former President Donald Trump-related Truth Social platform’s launch faced challenges, regulatory
0 Comments
Novavax (NASDAQ:NVAX) was so close to hitting gold, but the delay in FDA approval for its Covid-19 vaccine has taken the life out of this stock, leaving a lot of investors wondering — what’s next? After reporting its first-quarter results, NVAX stock dipped 20% and hit $43. Despite making the right moves and filing for
0 Comments